AI: Image analytics in the lab: game changer or ineffective add-on?

Nikica Zaninovic, Ph.D., is Embryology Laboratory Director and Associate Professor of Embryology in Clinical Obstetrics & Gynecology and Clinical Reproductive Medicine at the Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine of Weill Cornell Medical College.

In addition to his clinical duties, Dr. Zaninovic has ongoing research projects in human embryonic stem cell (hESCs) derivation. As Manager and Principal Investigator of Weill Cornell’s hESC Derivation Laboratory, Dr. Zaninovic has derived 43 stem cell lines. Articles based on this work have appeared in Nature, Blood and Fertility and Sterility. In 2013, Dr. Zaninovic registered Weill Cornell Medical College’s first human embryonic stem cell line with the National Institutes of Health, making this line available for use by researchers from around the world. At the time of its registration, there were only 210 other registered lines.

Dr. Zaninovic received his Masters and Ph.D. degrees in Biology from the University of Zagreb, Croatia. He is double-certified as a High-complexity Laboratory Director (H.C.L.D.) and Embryology Laboratory Director (E.L.D.) by the American Association of Bioanalysts. In 1990, he was responsible for South America’s first successful intracytoplasmic sperm injection (ICSI) and preimplantation genetic diagnosis (PGD) pregnancies. In 1995, he joined Weill Cornell as a supervisor in the Embryology Laboratory and was subsequently appointed the Lab’s Director in 2010. His interests include clinical and experimental embryology as well as stem cell biology.